-
Something wrong with this record ?
Novel CYP24A1 Mutation in a Young Male Patient with Nephrolithiasis: Case Report
J. Jiráčková, R. Hyšpler, S. Alkanderi, L. Pavlíková, V. Palicka, JA. Sayer,
Language English Country Switzerland
Document type Case Reports
NLK
Directory of Open Access Journals
from 2013
Free Medical Journals
from 2010
ProQuest Central
from 1994-05-01 to 1 year ago
ProQuest Central
from 2017-01-01
Open Access Digital Library
from 2013-01-01
Medline Complete (EBSCOhost)
from 2005-01-01
Health & Medicine (ProQuest)
from 1994-05-01 to 1 year ago
Health & Medicine (ProQuest)
from 2017-01-01
Karger Open Access
from 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1996
PubMed
31288237
DOI
10.1159/000500922
Knihovny.cz E-resources
- MeSH
- Vitamin D3 24-Hydroxylase genetics MeSH
- Hypercalcemia MeSH
- Hypercalciuria MeSH
- Kidney Calculi genetics MeSH
- Humans MeSH
- Young Adult MeSH
- Mutation * MeSH
- Sequence Analysis, DNA MeSH
- Siblings MeSH
- Vitamin D blood MeSH
- Check Tag
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Publication type
- Case Reports MeSH
BACKGROUND/AIMS: The CYP24A1 gene encodes the vitamin D 24-hydroxylase enzyme, which hydroxylates active forms of vitamin D into inactive forms. Biallelic mutations in the CYP24A1 gene can lead to elevated levels of active vitamin D metabolites and, consequently, to hypercalcemia, hypercalciuria, nephrocalcinosis, and nephrolithiasis; however, monoallelic mutations have been associated only with milder phenotypes. In the present manuscript, we report the case of a young male patient who presented hypercalcemia and nephrolithiasis, suppressed parathormone, and elevated 1,25 dihydroxy vitamin D levels. METHODS: Biochemical analyses were performed on Cobas 8000, F. Hoffmann-La Roche AG, Basel, Switzerland. The proband was initially evaluated for occult malignancies by body imaging, serum electrophoresis, and tumor markers, which did not reveal any pathology. DNA samples of the proband and his sibling were then examined using Sanger sequencing. RESULTS: Genetic analysis revealed 2 compound heterozygous CYP24A1 mutations (p.L148P and p.R223*). The novel nonsense CYP24A1 mutation, p.R223*, was also found heterozygously in other family members with a medical history of nephrolithiasis. CONCLUSIONS: The identification of this gene mutation causing hypercalcemia, hypercalciuria, and renal stones allows the specific management of endogenous vitamin D production.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006168
- 003
- CZ-PrNML
- 005
- 20200518132403.0
- 007
- ta
- 008
- 200511s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000500922 $2 doi
- 035 __
- $a (PubMed)31288237
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Jiráčková, Jana $u Institute for Clinical Biochemistry and Diagnostics, Department of Clinical Osteology, University Hospital Hradec Králové, Hradec Králové, Czechia, jana.jirackova@fnhk.cz. Department of Gerontology and Metabolism, University Hospital Hradec Králové, Hradec Králové, Czechia, jana.jirackova@fnhk.cz. Faculty of Medicine, Charles University, Hradec Králové, Czechia, jana.jirackova@fnhk.cz.
- 245 10
- $a Novel CYP24A1 Mutation in a Young Male Patient with Nephrolithiasis: Case Report / $c J. Jiráčková, R. Hyšpler, S. Alkanderi, L. Pavlíková, V. Palicka, JA. Sayer,
- 520 9_
- $a BACKGROUND/AIMS: The CYP24A1 gene encodes the vitamin D 24-hydroxylase enzyme, which hydroxylates active forms of vitamin D into inactive forms. Biallelic mutations in the CYP24A1 gene can lead to elevated levels of active vitamin D metabolites and, consequently, to hypercalcemia, hypercalciuria, nephrocalcinosis, and nephrolithiasis; however, monoallelic mutations have been associated only with milder phenotypes. In the present manuscript, we report the case of a young male patient who presented hypercalcemia and nephrolithiasis, suppressed parathormone, and elevated 1,25 dihydroxy vitamin D levels. METHODS: Biochemical analyses were performed on Cobas 8000, F. Hoffmann-La Roche AG, Basel, Switzerland. The proband was initially evaluated for occult malignancies by body imaging, serum electrophoresis, and tumor markers, which did not reveal any pathology. DNA samples of the proband and his sibling were then examined using Sanger sequencing. RESULTS: Genetic analysis revealed 2 compound heterozygous CYP24A1 mutations (p.L148P and p.R223*). The novel nonsense CYP24A1 mutation, p.R223*, was also found heterozygously in other family members with a medical history of nephrolithiasis. CONCLUSIONS: The identification of this gene mutation causing hypercalcemia, hypercalciuria, and renal stones allows the specific management of endogenous vitamin D production.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperkalcemie $7 D006934
- 650 _2
- $a hyperkalciurie $7 D053565
- 650 _2
- $a ledvinové kameny $x genetika $7 D007669
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a sekvenční analýza DNA $7 D017422
- 650 _2
- $a sourozenci $7 D035781
- 650 _2
- $a vitamin D $x krev $7 D014807
- 650 _2
- $a CYP24A1 $x genetika $7 D065668
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Hyšpler, Radomir $u Institute for Clinical Biochemistry and Diagnostics, Department of Clinical Osteology, University Hospital Hradec Králové, Hradec Králové, Czechia. Faculty of Medicine, Charles University, Hradec Králové, Czechia.
- 700 1_
- $a Alkanderi, Sumaya $u Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.
- 700 1_
- $a Pavlíková, Ladislava $u Institute for Clinical Biochemistry and Diagnostics, Department of Clinical Osteology, University Hospital Hradec Králové, Hradec Králové, Czechia. Faculty of Medicine, Charles University, Hradec Králové, Czechia.
- 700 1_
- $a Palicka, Vladimir $u Institute for Clinical Biochemistry and Diagnostics, Department of Clinical Osteology, University Hospital Hradec Králové, Hradec Králové, Czechia. Faculty of Medicine, Charles University, Hradec Králové, Czechia.
- 700 1_
- $a Sayer, John A $u Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom. Newcastle upon Tyne NHS Hospitals Foundation Trust, Newcastle, United Kingdom. NIHR Newcastle Biomedical Research Centre, Newcastle, United Kingdom.
- 773 0_
- $w MED00003064 $t Kidney & blood pressure research $x 1423-0143 $g Roč. 44, č. 4 (2019), s. 870-877
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31288237 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200518132403 $b ABA008
- 999 __
- $a ok $b bmc $g 1525026 $s 1096224
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 44 $c 4 $d 870-877 $e 20190709 $i 1423-0143 $m Kidney & blood pressure research $n Kidney Blood Press Res $x MED00003064
- LZP __
- $a Pubmed-20200511